«Immunization Schedule

Below is an extended Immunization Schedule patents listing. Click here to return to the Immunization Schedule main in depth entry.

Patents :
US Patent No.	Title
7355015	Matriptase, a serine protease and its applications
7385047	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7387894	Recombinant viral-based malaria vaccines
7388090	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7390493	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7393949	Human immunodeficiency virus (HIV) nucleotide sequences
7396532	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7396662	C-type lectin polypeptides
7402298	EphA2 monoclonal antibodies and methods of making and using same
7402317	Anti-cancer vaccine
7384785	Diagnostic test for West Nile virus
7384640	Mutant cholera holotoxin as an adjuvant
7381816	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7358222	Preventing airway mucus production by administration of EGF-R antagonists
7358353	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
7361329	Compositions for inducing an immune response
7361338	Methods to inhibit growth of prostate cancer cells
7371825	Anti-MCP-1 antibodies, compositions, methods and uses
7378258	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7378514	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7381561	Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
7381814	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7381815	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7402655	Molecules designated LDCAM
7404958	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7417113	PSCA: prostate stem cell antigen and uses thereof
7420039	Individualized anti-cancer antibodies
7422742	Methods for using human monoclonal antibodies to interleukin-5
7425335	Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus
7425428	Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby
7427399	Antibodies and related molecules that bind to 161P2F10B proteins
7427498	Composition, methods and reagents for the synthesis of a soluble form of human PHEX
7432066	Non-invasive enzyme screen for tissue remodeling associated conditions
7432237	Methods of treating asthma by administering interleukin-17 receptor
7432346	Gene expressed in prostate cancer
7416877	Receptor that causes cell death and recombinant production thereof
7416862	Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
7416849	HBM variants that modulate bone mass and lipid levels
7405058	Human TSLP polynucleotides
7405270	CD40-Ligand lacking native-pattern glycosylation
7405290	Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
7405291	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
7407656	PSCA: prostate stem cell antigen and uses thereof
7408053	Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby
7410795	Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
7411050	Monoclonal blocking antibody to human RANKL
7411055	Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
7414108	Composition and method for producing an immune response against tumor-related antigens
7432356	Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.